Can Peripheral NIRS Predict the Response to a Fluid Challenge in Pediatric Patients: An Interventional Study
Sponsor
Erasme University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05111132
Collaborator
(none)
30
1
2
23
1.3
Study Details
Study Description
Brief Summary
This study will be conducted on pediatric patients up to 14 years of age. The effect of two fluid challenge regimes on cerebral and peripheral NIRS will be assessed, in a randomized double blinded controlled trial. The findings will be correlated with two ultrasound measures, previously validated as markers of fluid responsiveness.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Can Peripheral NIRS Predict the Response to a Fluid Challenge in Pediatric Patients: An Interventional Study
Anticipated Study Start Date
:
Oct 29, 2021
Anticipated Primary Completion Date
:
Sep 30, 2023
Anticipated Study Completion Date
:
Sep 30, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 7.5 ml/kg Group 1, receiving a fluid challenge of 7,5 ml/kg in 5 minutes |
Diagnostic Test: Fluid challenge (cristalloïd, NaCl 0,9%)
A fluid challenge according to group will be administrated by infusion pump
|
Experimental: 12.5 ml/kg Group 2, 12.5 ml/kg of fluid challenge in 5 minutes |
Diagnostic Test: Fluid challenge (cristalloïd, NaCl 0,9%)
A fluid challenge according to group will be administrated by infusion pump
|
Outcome Measures
Primary Outcome Measures
- Effect of fluid challenge on NIRS (peripheral/cerebral) [peri-operative]
Eligibility Criteria
Criteria
Ages Eligible for Study:
1 Year
to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
all operations excepting cardiac surgery
-
BMI < 30
-
ages 1-14 years
Exclusion Criteria:
-
any cardiac affection (congenital unoperated heart disease, arrythmias)
-
icterus
-
refusal
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Erasmus Hospital | Brussels | Belgium | 1070 |
Sponsors and Collaborators
- Erasme University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Lulia Scolobiuc,
Resident,
Erasme University Hospital
ClinicalTrials.gov Identifier:
NCT05111132
Other Study ID Numbers:
- P2021/055/CCB B4062021000019
First Posted:
Nov 8, 2021
Last Update Posted:
Nov 8, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No